𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Outcome after percutaneous closure of a patent foramen ovale using the Intrasept™ device : A multi-centre study

✍ Scribed by Justin G.L.M. Luermans; Martijn C. Post; Rainer Schräder; Thierry Sluysmans; Tom Vydt; Paul Vermeersch; Massimo Chessa; Eustaquio Onorato; Jean-Jacques Goy; Werner I.H.L. Budts

Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
142 KB
Volume
71
Category
Article
ISSN
1522-1946

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Percutaneous closure of patent foramen o
Percutaneous closure of patent foramen ovale with a bioabsorbable occluder device : Single-Centre Experience
✍ Gian Paolo Ussia; Valeria Cammalleri; Massimiliano Mulè; Marilena Scarabelli; Ma 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 192 KB 👁 2 views

## Abstract ## Background: Percutaneous closure of patent foramen ovale (PFO) is routinely performed with nonbiological devices, characterized by a persistent low‐grade inflammatory response. We report our experience about PFO closure with a bioabsorbable device, BioSTAR® (NMT Inc, USA). ## Metho

Implantation of a second closure device
Implantation of a second closure device in patients with residual shunt after percutaneous closure of patent foramen ovale
✍ Markus Schwerzmann; Stephan Windecker; Andreas Wahl; Krassen Nedeltchev; Heinric 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 230 KB 👁 1 views

## Abstract Percutaneous closure of patent foramen ovale (PFO) in patients with presumed paradoxical embolism yields complete occlusion in > 90% of patients using contemporary closure devices. Patients with a residual shunt after percutaneous PFO closure have been found at increased risk for recurr

Iatrogenic atrial septal defect, erosion
Iatrogenic atrial septal defect, erosion of the septum primum after device closure of a patent foramen ovale as a new medical entity
✍ Bernhard Meier 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 179 KB 👁 1 views

## Abstract Iatrogenic atrial septal defects are described in 2 patients. They occurred after implantation of Amplatzer occluders to close a patent foramen ovale. While device erosions to the extra‐atrial space have been described, erosion induced atrial septal defects are a new medical entity. The